AI assistant
Sending…
Immuron Ltd — Report Publication Announcement 2011
Sep 5, 2011
35121_rns_2011-09-05_e4e40fc7-ed8d-4bca-98c5-ee53ef5dd316.pdf
Report Publication Announcement
Open in viewerOpens in your device viewer
==> picture [188 x 41] intentionally omitted <==
ABN: 80 063 114 045 Level 1, 39 Leveson Street North Melbourne, Vic 3051 Tel: +61 3 8637 1107 Fax: +61 3 9328 1675 www.immuron.com
6 September 2011
ASX Announcement
Immuron Limited Research Report
Immuron Limited is pleased to announce that it has commissioned Alpha Securities to prepare a research report on the Company’s Progressing Development of NASH and Influenza Drug Candidates.
This research report is available for viewing or downloaded from the Company’s website under the Investor Relations and News section, shareholder information tab; www.immuron.com
==> picture [210 x 96] intentionally omitted <==
Graeme Stevens Company Secretary
1
More from Immuron Ltd
Regulatory Filings
2026
May 27
Investor Presentation
2026
May 7
Investor Presentation
2026
Apr 29
Earnings Release
2026
Apr 16
Regulatory Filings
2026
Apr 13
Capital/Financing Update
2026
Apr 12
Regulatory Filings
2026
Mar 10
Investor Presentation
2026
Mar 4
Major Shareholding Notification
2026
Feb 26
Interim / Quarterly Report
2026
Feb 24